A Nursing Guide to Infusion Therapy with Abatacept for the Treatment of Rheumatoid Arthritis

被引:0
|
作者
Barr, Christine [1 ]
机构
[1] Ctr Rheumatol, New York, NY 10028 USA
关键词
D O I
10.1097/01.NAN.0000264713.26219.2e
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation of the synovial membranes and progressive joint destruction. Increased understanding of the immunopathology of RA has resulted in the development of new therapies to manage the disease, including several infusion-based therapies. Abatacept, a selective costimulation modulator, has been shown to be effective in clinical trials. Abatacept has a mechanism of action that is different from any other biologic RA therapy, and it provides a valuable alternative for RA patients. This article provides practical guidance for nurses to ensure safe administration and to maximize patient outcomes with abatacept.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 50 条
  • [31] Abatacept for Treatment of Rheumatoid Arthritis: Special Focus on the Elderly
    Martin Soubrier
    Clement Lahaye
    Zuzana Tatar
    Drugs & Aging, 2018, 35 : 379 - 387
  • [32] Abatacept Therapy for Rheumatoid Arthritis in the Setting of Hepatitis C Infection
    Mahajan, Tina Dewan
    Hooker, Roderick
    Maher, Lisa
    Brown, Geri
    Reimold, Andreas
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2010, 16 (07) : 332 - 334
  • [33] Treatment Costs Cost Analysis of Infusion Therapy for treating rheumatoid Arthritis
    Thiem, Helena
    GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2018, 23 (02): : 60 - +
  • [34] PREDICTIVE FACTORS OF DISCONTINUATION OF THERAPY WITH ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Piantoni, S.
    Colombo, E.
    Tincani, A.
    Airo, P.
    Scarsi, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 518 - 518
  • [35] Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis
    Piantoni, Silvia
    Colombo, Enrico
    Tincani, Angela
    Airo, Paolo
    Scarsi, Mirko
    CLINICAL RHEUMATOLOGY, 2016, 35 (04) : 1065 - 1069
  • [36] Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritis
    Silvia Piantoni
    Enrico Colombo
    Angela Tincani
    Paolo Airò
    Mirko Scarsi
    Clinical Rheumatology, 2016, 35 : 1065 - 1069
  • [37] Predictive Factors of Persistence in Therapy with Abatacept in Patients with Rheumatoid Arthritis
    Piantoni, Silvia
    Colombo, Enrico
    Tincani, Angela
    Airo, Paolo
    Scarsi, Mirko
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [38] Abatacept (Orencia) for rheumatoid arthritis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1229): : 17 - 18
  • [39] Rituximab and abatacept in rheumatoid arthritis
    Gomez Centeno, Toni
    REUMATOLOGIA CLINICA, 2009, 5 : 77 - 81
  • [40] Abatacept: A Review in Rheumatoid Arthritis
    Hannah A. Blair
    Emma D. Deeks
    Drugs, 2017, 77 : 1221 - 1233